Unveiling Pfizer's Potent Cocktail: Key Drivers Of Free Cash Flow Growth
Pfizer announced positive results from a pivotal clinical trial evaluating Abrysvo's efficacy against respiratory syncytial ...
Meningitis survivor advocates against changing vaccine schedule
The CDC recommends the meningococcal conjugate (MenACWY) vaccine for all preteens and teens. The current vaccine schedule ...
French Stocks: Sanofi (SAN) to Revamp US Vaccine Operations, Trim Jobs
In key news on French stocks, Sanofi S.A. (FR:SAN) is reportedly planning to revamp its U.S. vaccine operations, including ...
FiercePharma14h
Regulatory tracker: GSK's 5-in-1 meningococcal vaccine accepted for FDA review
The combined study results showed that 26% of patients who received Velsipity achieved clinical remission, versus just 11% in the placebo group, at the 12-week mark. Pfizer ... up to $5.8 billion ...